from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1045/-

LFCtreatmentdescriptionclass of inhibitor

-0.593

Amikacinug/mL Amikacintranslation

-1.336

Cap5-10ug/mL Capreomycintranslation

-1.173

Rox10-50 ug/mL Roxithromycintranslation

-0.373

SM2-5 ug/mL Streptomycintranslation

-1.471

Tet5-10 ug/mL Tetracyclinetranslation

0.492

Rif0.2-5ug/mL Rifampicintranscription

0.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.280

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.415

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.083

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.205

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.592

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.363

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.201

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.051

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.292

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.493

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.614

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.399

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.758

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.660

KCN5-20 ug/mL Potassium cyaniderespiration

0.027

NaN30.2-2 mM Sodium aziderespiration

0.036

Nigericin50 uM Nigericinrespiration

0.277

TRC10-150 ug/mL Triclosanrespiration

0.287

TRZ10-25 ug/mL Thioridazinerespiration

0.204

Valinomycin0.5-10 uM Valinomycinrespiration

-1.405

ZnSO42 mM ZnSO4respiration

0.610

menadione6-10 ug/mL Menadionerespiration

-0.265

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.691

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.128

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.038

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.028

NRP_1Non-replicating persistence stage 1dosRassociated

0.173

Amp0.2mg/mL AmpicillincellWall

-0.743

Cephalexin20-100 ug/mL CephalexincellWall

-0.397

Cerulenin0.32-5 ug/mL CerulenincellWall

1.050

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.058

EMB10-20 ug/mL EthambutolcellWall

-1.177

Eta12-40 ug/mL EthionamidecellWall

-1.377

INH0.2-0.4 ug/mL IsoniazidcellWall

0.371

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.648

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.549

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.534

BZA0.12 mg/mL BenzamidearomaticAmides

-0.047

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.497

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.246

H2O24 mM hydrogen peroxideDNAdamaging

0.283

Levo10 ug/mL LevofloxacinDNAdamaging

0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.692

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.968

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.794

UVUV-irradiationDNAdamaging

0.942

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.233

Antimycin12.5-50 ug/mL Antimycin A?

0.931

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.093

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.310

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.274

PA8240.2-2 ug/mL PA-824?

-0.644

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.591

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.048

Verapamil50 uM Verapamil?

0.550

mercaptoethanol2 mM 2-Mercaptoethanol?

0.351

methoxatin10-20 ug/mL Methoxatin?